Panel discussion
Sartorius Stedim Switzerland AG
| Website: | https://www.sartorius.com/en/company/about-sartorius-ag |
| Date: | April 22, 2024 |
| Time: | 16:30-17:15 |
| Room: | Montreal |
Panel title
More with less: Expert insights on how process intensification can be used to achieve affordable and sustainable biologics manufacturing
Panel summary
Under the light of changing paradigms in the biopharmaceutical industry more and more focus is given on increasing the productivity, lowering the costs and speeding up the time to clinic. Can a intensified approach towards biopharmaceutical manufacturing shape the future of the whole industry?
Gain crucial insights from different viewpoints by attending the panel discussion with experienced industry leaders out of different functions, positions and modalities in the market.
Speaker information
Moderation
Gerben Zijlstra, Process Technology Manager, Sartorius Stedim Biotech
Panelists
Uwe Gottschalk, Operating Partner, Keensight Capital
Eduard Ayuso, Chief Technology Officer, Siegfried Dinamiqs
Georg Blaser, VP Biologics Development Center, Celonic AG
John Manneke, Global Category Manager Drug Substance, Roche AG
Thomas Villiger, Professor of Bioprocess Technology, FHNW
Company profile
Sartorius is a leading international partner of life sciences research and the biopharmaceutical industry. The Bioprocess Solutions division, with its broad product portfolio focusing on single-use solutions, helps customers manufacture biotech medications, vaccines, and cell and gene therapies safely, rapidly, and economically. The company, with its headquarter in Göttingen, Germany, has a strong global reach with around 60 production and sales sites worldwide.
